L2M Validate / Qc Winter 2026 / Pharma Matters Innovative solutions

Pharmaceutical supply chains in North America remain highly dependent on overseas manufacturing. Most critical active pharmaceutical ingredients (APIs) and fine chemicals essential for drug production are imported, making the region vulnerable to disruptions in global supply chains. Our initiative aims to strengthen pharmaceutical independence by developing local, sustainable, and innovative solutions. Our dedicated team of experts focuses on: a) Developing new, safe, eco-friendly, and scalable processes to produce critical APIs locally; b) Supporting the optimization of existing API synthesis routes through advanced technologies such as flow chemistry and process intensification; c) Advancing drug design and development using cutting-edge scientific approaches. By producing APIs domestically, we can reduce reliance on international suppliers, safeguard pharmaceutical production, and enhance national healthcare security. We currently count on scientific expertise and most of the physical infrastructure necessary to begin operations. Through the L2M Validate Program, we aim to strengthen our market knowledge, refine our business model, and secure the financial resources required to acquire equipment and launch the startup.

Faculty Supervisor:

Steven LaPlante

Student:

Partner:

V1 Studio

Discipline:

Life Sciences

Sector:

Education

University:

Université du Québec : Institut national de la recherche scientifique

Program: